Cadence Aspirin Patch
Welcome to Medical News TodayHealthline Media, Inc. Would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a ) using cookies and similar automatic collection tools in order to a) personalize content and/or offers on our site or other sites, b) communicate with you upon request, and/or c) for additional reasons upon notice and, when applicable, with your consent.Healthline Media, Inc. Is based in and operates this site from the United States. Any data you provide will be primarily stored and processed in the United States, pursuant to the laws of the United States, which may provide lesser privacy protections than European Economic Area countries.By clicking “accept” below, you acknowledge and grant your consent for these activities unless and until you withdraw your consent using our.
Learn more in our. Please accept our privacy termsWe use cookies and similar technologies to improve your browsing experience, personalize content and offers, show targeted ads, analyze traffic, and better understand you. We may share your information with third-party partners for marketing purposes. To learn more and make choices about data use, visit our. By clicking “Accept and Continue” below, (1) you consent to these activities unless and until you withdraw your consent using our rights request form, and (2) you consent to allow your data to be transferred, processed, and stored in the United States. The new patch is transparent and adheres well to skin, even when the drug load reaches levels as high as 30% of the patch weight.Image credit: Warwick UniversityThe patch was developed by researchers at the University of Warwick in the UK, led by research chemist Prof.
David Haddleton.The Food and Drug Administration (FDA) have recently strengthened the warning labels that accompany nonsteroidal anti-inflammatory drugs like ibuprofen.New labels warn that such drugs increase the risk of or, and these events happen without warning, potentially causing death. Furthermore, such risks are higher for people who take NSAIDs for a long time. The researchers say their patch paves the way for other novel long-acting pain relief products that can be used to treat common conditions - such as back pain, neuralgia and arthritis - without taking potentially damaging oral doses of the drug.Prof. Haddleton explains that, for the first time, they can 'produce patches that contain effective doses of active ingredients such as ibuprofen for which no patches currently exist.'
He adds that they are able to 'improve the drug loading and stickiness of patches containing other active ingredients to improve patient comfort and outcome.' The team notes that the drug load made possible by their new technology is 5-10 times that of current medical patches and gels. Furthermore, because the patch adheres well to skin, it stays put even when the drug load reaches levels as high as 30% of the weight or volume of the patch.
Pspice Cadence
There are currently a number of ibuprofen gels available, but the researchers say it is difficult to control dosage with these gels, and they are not convenient to apply.' There are only a limited number of existing polymers that have the right characteristics to be used for this type of transdermal patches - that will stick to the skin and not leave residues when being easily removed,' says Prof.
Haddleton, who adds:'Our success in developing this breakthrough patch design isn't limited to ibuprofen; we have also had great results testing the patch with methyl salicylate (used in liniments, gels and some leading commercial patches).We believe that many other over-the-counter and prescription drugs can exploit our technology, and we are seeking opportunities to test a much wider range of drugs and treatments within our patch.' Medherant CEO Nigel Davis says they anticipate their new patch will be on the market in around 2 years. He adds that they 'can see considerable opportunities in working with pharmaceutical companies to develop innovative products using our next-generation transdermal drug-delivery platform.' Despite the risks associated with long-term use of NSAIDs, Medical News Today recently reported on a study that suggested use of the drugs.
Please use one of the following formats to cite this article in your essay, paper or report:MLAEllis, Marie. 'New ibuprofen patch delivers drug without risks posed by oral dose.' Medical News Today. MediLexicon, Intl., 9 Dec. Mw2 unblocked. (2015, December 9).
Cadence Aspirin Patches
'New ibuprofen patch delivers drug without risks posed by oral dose.' Medical News Today. Retrieved from.Please note: If no author information is provided, the source is cited instead.